Cargando…

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Detalles Bibliográficos
Autores principales: Perez, Marco, Lucena-Cacace, Antonio, Marín-Gómez, Luis Miguel, Padillo-Ruiz, Javier, Robles-Frias, Maria Jose, Saez, Carmen, Garcia-Carbonero, Rocio, Carnero, Amancio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363656/
https://www.ncbi.nlm.nih.gov/pubmed/28074043
http://dx.doi.org/10.18632/oncotarget.13482
_version_ 1782517199665102848
author Perez, Marco
Lucena-Cacace, Antonio
Marín-Gómez, Luis Miguel
Padillo-Ruiz, Javier
Robles-Frias, Maria Jose
Saez, Carmen
Garcia-Carbonero, Rocio
Carnero, Amancio
author_facet Perez, Marco
Lucena-Cacace, Antonio
Marín-Gómez, Luis Miguel
Padillo-Ruiz, Javier
Robles-Frias, Maria Jose
Saez, Carmen
Garcia-Carbonero, Rocio
Carnero, Amancio
author_sort Perez, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-5363656
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53636562017-03-29 Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src Perez, Marco Lucena-Cacace, Antonio Marín-Gómez, Luis Miguel Padillo-Ruiz, Javier Robles-Frias, Maria Jose Saez, Carmen Garcia-Carbonero, Rocio Carnero, Amancio Oncotarget Correction Impact Journals LLC 2016-11-21 /pmc/articles/PMC5363656/ /pubmed/28074043 http://dx.doi.org/10.18632/oncotarget.13482 Text en Copyright: © 2016 Perez et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Perez, Marco
Lucena-Cacace, Antonio
Marín-Gómez, Luis Miguel
Padillo-Ruiz, Javier
Robles-Frias, Maria Jose
Saez, Carmen
Garcia-Carbonero, Rocio
Carnero, Amancio
Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_full Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_fullStr Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_full_unstemmed Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_short Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_sort correction: dasatinib, a src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-src
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363656/
https://www.ncbi.nlm.nih.gov/pubmed/28074043
http://dx.doi.org/10.18632/oncotarget.13482
work_keys_str_mv AT perezmarco correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT lucenacacaceantonio correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT maringomezluismiguel correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT padilloruizjavier correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT roblesfriasmariajose correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT saezcarmen correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT garciacarbonerorocio correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc
AT carneroamancio correctiondasatinibasrcinhibitorsensitizeslivermetastaticcolorectalcarcinomatooxaliplatinintumorswithhighlevelsofphosphosrc